Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Sep 21, 2023

SELL
$51.49 - $81.64 $1.8 Million - $2.86 Million
-35,000 Reduced 70.0%
15,000 $874,000
Q2 2022

Aug 15, 2022

BUY
$51.49 - $81.64 $772,350 - $1.22 Million
15,000 New
15,000 $875,000
Q4 2021

Feb 14, 2022

SELL
$47.97 - $62.21 $2.4 Million - $3.11 Million
-50,000 Closed
0 $0
Q3 2021

Sep 21, 2023

BUY
$54.64 - $61.3 $1.26 Million - $1.41 Million
23,000 Added 85.19%
50,000 $2.8 Million
Q3 2021

Nov 15, 2021

BUY
$54.64 - $61.3 $2.73 Million - $3.07 Million
50,000 New
50,000 $2.8 Million
Q2 2021

Aug 16, 2021

SELL
$59.18 - $69.99 $1.6 Million - $1.89 Million
-27,000 Closed
0 $0
Q1 2021

Sep 21, 2023

SELL
$59.31 - $78.82 $2.67 Million - $3.55 Million
-45,000 Reduced 62.5%
27,000 $1.89 Million
Q1 2021

May 14, 2021

SELL
$59.31 - $78.82 $2.67 Million - $3.55 Million
-45,000 Reduced 62.5%
27,000 $1.89 Million
Q4 2020

Sep 21, 2023

BUY
$50.47 - $66.26 $3.63 Million - $4.77 Million
72,000 New
72,000 $4.31 Million
Q4 2020

Feb 16, 2021

BUY
$50.47 - $66.26 $3 Million - $3.94 Million
59,400 Added 471.43%
72,000 $4.31 Million
Q2 2020

Aug 14, 2020

SELL
$30.8 - $52.47 $2.68 Million - $4.56 Million
-87,000 Reduced 87.35%
12,600 $661,000
Q1 2020

May 15, 2020

BUY
$28.4 - $50.7 $2.83 Million - $5.05 Million
99,600 New
99,600 $3.34 Million
Q4 2019

Feb 13, 2020

SELL
$36.31 - $46.83 $384,886 - $496,398
-10,600 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$35.66 - $44.99 $21,395 - $26,994
600 Added 6.0%
10,600 $404,000
Q2 2019

Aug 14, 2019

SELL
$36.57 - $47.97 $91,425 - $119,925
-2,500 Reduced 20.0%
10,000 $435,000
Q4 2018

Feb 14, 2019

SELL
$41.31 - $52.16 $1.84 Million - $2.32 Million
-44,500 Reduced 78.07%
12,500 $538,000
Q3 2018

Nov 14, 2018

BUY
$32.85 - $52.0 $1.28 Million - $2.03 Million
39,100 Added 218.44%
57,000 $2.8 Million
Q2 2018

Aug 14, 2018

BUY
$27.5 - $39.8 $492,250 - $712,420
17,900 New
17,900 $574,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.22B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.